Zurich Cantonal Bank’s Merck MRK Stock Holding History

Zurich Cantonal Bank’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-954,267	Closed	-$100M	–	3136
2025 Q4	$100M	Buy	+954,267	New	+$89.6M	0.22%	84

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zurich Cantonal Bank's MRK Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Merck (MRK) stake by 45% in Q2 2026, buying an estimated $53.6M and bringing the position to 1,482,295 shares worth $190M. The position accounts for 0.36% of the portfolio, ranked #47.

Zurich Cantonal Bank first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,851 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Zurich Cantonal Bank held 1,482,295 shares of Merck worth $190M as of Q2 2026.
Zurich Cantonal Bank bought 457,995 Merck shares in Q2 2026, an estimated $53.6M.
Merck made up 0.36% of Zurich Cantonal Bank's portfolio in Q2 2026, its #47 holding.
Zurich Cantonal Bank first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,851 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.